Healthcare

GSK plc (LON:GSK),a global biopharmaceutical company headquartered in the UK, has announced financial terms related to a recently disclosed mRNA patent settlement between CureVac and BioNTech. As part of this agreement, GSK will receive a total of GBP 370 million upfront, along with ongoing …

Futura Medical plc (AIM:FUM)has confirmed the appointment of Alex Duggan to its Board of Directors as interim Chief Executive Officer, following completion of all necessary due diligence and regulatory procedures. The appointment was initially announced on 8 July 2025 as part of a broader …

Hikma Pharmaceuticals PLC (LSE: HIK.L), the multinational pharmaceutical group headquartered in the United Kingdom, has received a fresh endorsement from equity research houseBerenberg. AnalystVictoria Lamberthas reaffirmed herBuyrecommendation on the stock, assigning a price target ofAUD 52.75— representing a significant46.29% potential upsidefrom the current trading …

Smith+Nephew plc (LSE:SN, NYSE:SNN),a global medical technology company, has released results for the six months ended 28 June 2025, reporting increases in trading profit, cash generation, and earnings per share. Underlying revenue grew 5.0% in the first half, with reported revenue rising 4.7%, reflecting …

Kooth Plc (LSE:KOO), a pioneering provider of digital mental health solutions, has received a wave of optimism from the market asthree leading analysts – Stifel Europe, Canaccord Genuity, and Berenberg – reaffirmed BUY ratings

Highlights

AstraZeneca to invest $50 billion in U.S. R&D and manufacturing by 2030.